Navigation Links
Shareholder Proposals and Director Nominations Due November 5, 2007
Date:10/24/2007

MOUNT LAUREL, N.J., Oct. 24 /PRNewswire-FirstCall/ -- MedQuist Inc. (Pink Sheets: MEDQ) previously announced on October 15, 2007 that it intends to hold its 2007 annual meeting of shareholders within thirty days of the date on which a definitive proxy statement is mailed to its shareholders in order to, among other things, elect individuals to serve on MedQuist's Board of Directors.

Shareholders who wish to have a proposal considered for inclusion in the MedQuist proxy statement for this annual meeting must send their proposal to MedQuist so that it is received no later than November 5, 2007. Any shareholder proposal must comply with the requirements established by the Securities and Exchange Commission (SEC) in order to be included in the proxy statement. In addition, any shareholder wishing to nominate a candidate for director at this annual meeting must submit such nomination and any other information required by Section 4.8 of MedQuist's Amended and Restated By- laws, so that it is received no later than November 5, 2007. Shareholder proposals and nominations should be directed to the Secretary of MedQuist, Inc. at 1000 Bishops Gate Blvd., Suite 300, Mount Laurel, New Jersey 08054- 4632.

NOTICE TO SHAREHOLDERS:

In connection with MedQuist's upcoming annual meeting of shareholders, it will be filing a proxy statement and potentially other relevant documents concerning the annual meeting with the SEC. BEFORE MAKING ANY DECISION REGARDING ANY OF THE BUSINESS PROPERLY BROUGHT BEFORE THE ANNUAL MEETING, SHAREHOLDERS ARE URGED TO READ THE PROXY STATEMENT AND ANY OTHER RELEVANT DOCUMENTS FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION. Shareholders can obtain free copies of the proxy statement and other documents when they become available by contacting Investor Relations, MedQuist Inc., 1000 Bishops Gate Blvd., Suite 300, Mt. Laurel, NJ 08054. In addition, documents filed with the SEC will be available at no charge on the SEC's website at http://www.sec.gov. MedQuist and its executive officers and directors may, under SEC rules, be deemed to be participants in the solicitation of proxies from shareholders in connection with the upcoming annual meeting. Certain information about such individuals (including their ownership of shares of our common stock) is set forth in MedQuist's Annual Report on Form 10-K for the year ended December 31, 2006, which is available free of charge from MedQuist and the SEC as indicated above.

About MedQuist:

MedQuist is a leading provider of clinical documentation workflow solutions in support of the electronic health record. MedQuist provides electronic medical transcription, health information and document management products and services, including digital dictation, speech recognition, Web- based transcription, electronic signature, medical coding, mobile dictation devices, and outsourcing services.

Disclosure Regarding Forward-Looking Statements:

Some of the statements in this Press Release constitute "forward-looking statements" within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. These statements are not historical facts but rather are based on MedQuist's current expectations, estimates and projections regarding our business, operations and other factors relating thereto. Words such as "may," "will," "could," "would," "should," "anticipate," "predict," "potential," "continue," "expects," "intends," "plans," "projects," "believes," "estimates" and similar expressions are used to identify these forward-looking statements. The forward-looking statements contained in this Press Release include, without limitation, statements about the timing of making filings with the SEC related to an upcoming annual meeting of shareholders as well as statements regarding the timing of holding such meeting. These statements are only predictions and as such are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. For a discussion of these risks, uncertainties and assumptions, any of which could cause MedQuist's actual results to differ from those contained in the forward-looking statement, see the section of MedQuist's Annual Report on Form 10-K for the year ended December 31, 2006, entitled "Risk Factors" and discussions of potential risks and uncertainties in MedQuist's subsequent filings with the SEC.


'/>"/>
SOURCE MedQuist Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Medics worried over new proposals
2. AMA Rejects PBS Measure and Share Proposals
3. Single Women and Lesbians To Enjoy Full Rights in Donor Child Proposals
4. Tuberculosis Experts Outline Proposals to Speed Up Drug Development
5. DNA Directory Under Construction For Indian Criminals !
6. Clash of Difference of perceptions in food policy among Principals’ and Director
7. WHO Director-General passes away on 23rd of May
8. Pro-reservation body seeks removal of AIIMS Director
9. AIIMS Director Venugopal Sacked
10. China Nominates Margaret Chan to Run for WHO Director-Generals Post
11. Canada: On Popular Demand, Tamiflu finds a Berth in the Directory of Patent Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... As a ... Magna Cum Laude and his M.D from the David Geffen School of Medicine at ... returned to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of Astellas Farma ... as the company,s second affiliate in Latin America . ... ... Astellas Farma Colombia ... ...
(Date:6/23/2016)... 2016 Research and Markets has ... Global Analysis (United States, China, Japan, Brazil, United Kingdom, ... their offering. Surgical ... business planners, provides surgical procedure volume data in a ... an in-depth analysis of growth drivers and inhibitors, including ...
Breaking Medicine Technology: